Powering the next era of genomics through blockchain technology – protecting identity, personalizing healthcare, transforming lives.
To make the direct-to-consumer business more open, fair, and beneficial to all users, the Shivom platform uses blockchain technology to create a disruptive genomics ecosystem. It ensures data is owned by the data donors themselves. It ensures a transparent and secure bridge to organizations interested in using that data.
The cost of DNA sequencing has fallen significantly. It is anticipated that by the end of the decade it will be possible to generate a person’s entire genome for less than $100. Looking ahead further, we will see dramatically lower costs for genomic analysis services.
This will make personalized healthcare insights accessible to almost all individuals around the globe. As recently as January 2017, the worldwide leading sequencing provider Illumina unveiled a new sequencer, the NovaSeq, that the company reports will eventually provide a whole genome for less than $100. This presents a new dawn for access to personalized and precision healthcare on a global scale.
Within 2 weeks
|Round||Token Price||Bonus||Min / Max Purchase||Soft Cap||Hard Cap|
Public sale —
03 May 00:00 UTC
10 May 00:00 UTC
|0.11 USD||No||-||15,000 ETH||35,000,000 USD|
16 Apr 13:00 UTC
27 Apr 13:00 UTC
Shivom Roadshow starts
Private round raised from major crypto vc's
Establishment of sequencing processes and protocols
Worldwide rollout of Shivom platform
Formation Shivom research division